Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Essential thrombocythaemia | x | ||||||||||||||
Myeloproliferative disorder | x | x | x | x | x | x | x | x | x | x | x | ||||
Thrombocytosis | x | x | x | x | x | x | x | ||||||||
Thrombosis | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |